Troubled Chinese Insurer Anbang Interviews Banks About Asset Divestments: Sources
Anbang Insurance Group Co., the troubled Chinese insurer seized by the government, is interviewing investment banks to advise on potential asset divestments, people with knowledge of the matter said.
The once-acquisitive insurer plans to hire an adviser to manage the sale of parts of its portfolio, according to the people, who asked not to be identified because the information is private. Some bankers were in Beijing earlier this month pitching officials from Anbang and the Chinese banking and insurance regulator, one of the people said.
Advisers may also help find new investors to buy a stake in Anbang, the people said.
The Chinese government took temporary control of Anbang in February, saying at the time it would consider “all or partial” sales of its assets. Anbang burst onto the global scene in 2014 with the $1.95 billion purchase of New York’s Waldorf Astoria hotel and continued its buying binge by snapping up financial companies and marquee properties around the world.
The China Banking and Insurance Regulatory Commission didn’t immediately respond to a fax seeking comment. Anbang currently has no plan to dispose assets, its public relations department said in response to Bloomberg queries.
Anbang bought Dutch insurer Vivat NV in 2015 and agreed to invest 1.35 billion euros ($1.7 billion) to recapitalize the company. The next year, it acquired Strategic Hotels & Resorts Inc. for about $6.5 billion, gaining a portfolio of luxury properties including San Francisco’s Westin St. Francis and JW Marriott Essex House in New York.
The Chinese company also owns controlling stakes in South Korea’s Tongyang Life Insurance Co., Antwerp-based insurer Fidea NV and Belgian lender Nagelmackers.
China’s government has been seeking to broker the sale of a stake in Anbang, Bloomberg News reported in January. Regulators said last week that Anbang will start the selection of strategic investors and aim to introduce private capital as soon as possible.
Related:
- China’s Anbang Gets $9.7B Capital Injection to Bolster Solvency After Alleged Fraud
- Ex-Chairman of China’s Anbang ‘Doesn’t Deserve Leniency,’ Say Prosecutors
- Former Chairman of China’s Anbang Pleads for Leniency in $10B Fraud Trial
- Anbang’s Former Chairman Goes on Trial, Accused of Masterminding $10.4B Fraud
- China’s Anbang ‘Committed’ to Overseas Units After Government Takeover
- China Seizes Control of Anbang; Acquisitive Chairman Faces Fraud Prosecution
- Q&A on China’s Takeover of Giant Anbang Insurance
- China Seeks to Broker Sale of a Stake in Anbang Insurance: Sources
- As China’s Insurance Market Liberalizes, There Will Be Many Winners: Opinion
- China’s Move to Curb Overseas Deals Designed to Avoid Japan-Style Bust
- Quick Selldown of Anbang’s Overseas Assets May Prove Difficult
- New York’s Waldorf Owner Pressured to Sell as China Clampdown Escalates
- Chinese Government Asks Anbang Insurance to Sell Overseas Assets: Sources